Verona Pharma PLC ADR
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $940 | $0 |
Gross Profit | -270 | -262 | 730 | -154 |
EBITDA | -68,229 | -26,919 | -19,050 | -14,731 |
EBIT | -68,499 | -27,182 | -19,258 | -14,886 |
Net Income | -70,914 | -25,779 | -14,254 | -14,687 |
Net Change In Cash | 0 | 0 | 940 | 0 |
Free Cash Flow | -16,784 | -13,982 | -10,420 | -12,727 |
Cash | 404,598 | 254,882 | 271,772 | 257,366 |
Basic Shares | 81,027 | 80,712 | 80,267 | 79,779 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $458 | $458 | $40,000 | $2 |
Gross Profit | -679 | 112 | 40,000 | -627 |
EBITDA | -67,151 | -62,659 | -57,040 | -65,266 |
EBIT | -67,830 | -63,295 | -57,669 | -65,893 |
Net Income | -54,579 | -68,701 | -55,569 | -65,146 |
Net Change In Cash | 458 | 458 | 40,000 | 2 |
Free Cash Flow | -50,416 | -59,891 | -33,266 | -45,158 |
Cash | 271,772 | 227,827 | 148,380 | 187,986 |
Basic Shares | 79,267 | 66,133 | 59,148 | 32,866 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.88 |
2024-03-31 | -$0.32 |
2023-12-31 | -$0.18 |
2023-09-30 | -$0.18 |
